Abstract: Modern embedded systems are evolving quickly, demanding innovative approaches to software development across various domains. Selecting the right programming language is crucial for ...
MURRAY, Ky. — Murray State University has received approval from the Kentucky Council on Postsecondary Education marking a significant step toward allowing the university to offer a Doctorate of ...
New pipeline candidate AKTX-102 leverages Akari’s proprietary PH1 spliceosome payload and a novel antibody construct to address one of oncology’s most challenging and valuable solid tumor targets, ...
Company expands its ADC pipeline and patent estate for novel, differentiated ADCs New pipeline candidate AKTX-102 leverages Akari’s proprietary PH1 spliceosome payload and a novel antibody construct ...
Abstract: This paper describes a low-power voice-activated prototype providing a hands-free user interface for voice commands. Utilizing a microelectromechanical-system microphone, the device extracts ...
TAMPA and LONDON, Jan. 26, 2026 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology company pioneering next-generation antibody drug conjugates (ADCs) powered by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results